Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Nelson

Showing results (451-460 of 519) with videos related to

Pageof 52
Sort By:
Schizophrenia Research|May 5, 1999
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitroF P Bymaster, D L Nelson, N W DeLapp, et al.
Molecular Pharmacology|March 1, 1993
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptorD B Wainscott, M L Cohen, K W Schenck, et al.
Human Molecular Genetics|October 1, 1994
Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomesA M van den Ouweland, W H Deelen, C B Kunst, et al.
Molecular Ecology Resources|July 30, 2025
An Optimised Method to Identify Reintroduced Swift Foxes (Vulpes velox) Through SNP Genotyping of Non-Invasively Collected Scat Samples Using In-Solution Hybridisation CaptureL D Parker, K R Todd, D L Nelson, et al.
Nucleic Acids Research|December 22, 2022
Telomerase RNA in Hymenoptera (Insecta) switched to plant/ciliate-like biogenesisPetr Fajkus, Matej Adámik, Andrew D L Nelson, et al.
Nature Genetics|September 1, 1994
Length of uninterrupted CGG repeats determines instability in the FMR1 geneE E Eichler, J J Holden, B W Popovich, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Synthesis and biological activity of some known and putative duloxetine metabolitesF Kuo, T A Gillespie, P Kulanthaivel, et al.
Journal of Clinical Microbiology|March 1, 1989
Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infectionsD K Wagner, P Muelenaer, F W Henderson, et al.
Cytokine|January 7, 2000
Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2H Kobayashi, Y Tagaya, E S Han, et al.
The Journal of Clinical Investigation|December 1, 1976
The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.
Pageof 52

Showing results (451-460 of 519) with videos related to

Sort By:
Pageof 52
Schizophrenia Research|May 5, 1999
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitroF P Bymaster, D L Nelson, N W DeLapp, et al.
Molecular Pharmacology|March 1, 1993
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptorD B Wainscott, M L Cohen, K W Schenck, et al.
Human Molecular Genetics|October 1, 1994
Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomesA M van den Ouweland, W H Deelen, C B Kunst, et al.
Molecular Ecology Resources|July 30, 2025
An Optimised Method to Identify Reintroduced Swift Foxes (Vulpes velox) Through SNP Genotyping of Non-Invasively Collected Scat Samples Using In-Solution Hybridisation CaptureL D Parker, K R Todd, D L Nelson, et al.
Nucleic Acids Research|December 22, 2022
Telomerase RNA in Hymenoptera (Insecta) switched to plant/ciliate-like biogenesisPetr Fajkus, Matej Adámik, Andrew D L Nelson, et al.
Nature Genetics|September 1, 1994
Length of uninterrupted CGG repeats determines instability in the FMR1 geneE E Eichler, J J Holden, B W Popovich, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Synthesis and biological activity of some known and putative duloxetine metabolitesF Kuo, T A Gillespie, P Kulanthaivel, et al.
Journal of Clinical Microbiology|March 1, 1989
Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infectionsD K Wagner, P Muelenaer, F W Henderson, et al.
Cytokine|January 7, 2000
Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2H Kobayashi, Y Tagaya, E S Han, et al.
The Journal of Clinical Investigation|December 1, 1976
The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.
Pageof 52